| 12312344 |
N-substituted-dioxocyclobutenylamino-3-hydroxy-picolinamides useful as CCR6 inhibitors |
Brian Stephen Gerstenberger, Andrew Christopher Flick, Daniel Wei-Shung Kung, Vincent Michael Lombardo, James John Mousseau +7 more |
2025-05-27 |
|
| 11708360 |
N-substituted-dioxocyclobutenylamino-3-hydroxy-picolinamides useful as CCR6 inhibitors |
Brian Stephen Gerstenberger, Andrew Christopher Flick, Daniel Wei-Shung Kung, Vincent Michael Lombardo, James John Mousseau +7 more |
2023-07-25 |
$554,221,000 |
| 11655252 |
Aminopyrimidinyl derivatives |
Brian Stephen Gerstenberger, Wenhua Jiao, Manjinder Singh Lall, Ricardo Lira |
2023-05-23 |
$1,152,909,000 |
| 10975065 |
N-substituted-dioxocyclobutenylamino-3-hydroxy-picolinamides useful as CCR6 inhibitors |
Brian Stephen Gerstenberger, Andrew Christopher Flick, Vincent Michael Lombardo, James John Mousseau, Philippe Marcel Nuhant +7 more |
2021-04-13 |
$1,297,023,000 |
| 10815213 |
Bruton's tyrosine kinase inhibitors |
John Robert Springer, Balekudru Devadas, Danny James Garland, Margaret L. Grapperhaus, Seungil Han +9 more |
2020-10-27 |
$309,700,000 |
| 10426135 |
Methyl- and trifluromethyl-substituted pyrrolopyridine modulators of RORC2 and methods of use thereof |
Andrew Christopher Flick, Peter Jones, Neelu Kaila, Scot Richard Mente, John David Trzupek +6 more |
2019-10-01 |
$298,967,000 |
| 10385036 |
Sulfonamide-substituted indole modulators of RORC2 and methods of use thereof |
Andrew Christopher Flick, Peter Jones, Neelu Kaila, Scot Richard Mente, John David Trzupek +6 more |
2019-08-20 |
$837,148,000 |
| 10336748 |
Methyoxy-substituted pyrrolopyridine modulators of RORC2 and methods of use thereof |
Andrew Christopher Flick, Peter Jones, Neelu Kaila, Scot Richard Mente, John David Trzupek +6 more |
2019-07-02 |
$980,917,000 |
| 10266513 |
Bruton's tyrosine kinase inhibitors |
John Robert Springer, Balekudru Devadas, Danny James Garland, Margaret L. Grapperhaus, Seungil Han +9 more |
2019-04-23 |
$877,937,000 |
| 10227346 |
Methyl- and trifluoromethyl-substituted pyrrolopyridine modulators of RORC2 and methods of use therof |
Andrew Christopher Flick, Peter Jones, Neelu Kaila, Scot Richard Mente, John David Trzupek +6 more |
2019-03-12 |
$419,848,000 |
| 9920054 |
Methyl- and trifluoromethyl-substituted pyrrolopyridine modulators of RORC2 and methods of use thereof |
— |
2018-03-20 |
$310,972,000 |
| 9670201 |
Methyl- and trifluoromethyl-substituted pyrrolopyridine modulators of RORC2 and methods of use thereof |
Andrew Christopher Flick, Peter Jones, Neelu Kaila, Scot Richard Mente, John David Trzupek +5 more |
2017-06-06 |
$303,831,000 |
| 6903097 |
Heterocycle carboxamides as antiviral agents |
Fred Lawrence Ciske, John R. Palmer, Valerie A. Vaillancourt |
2005-06-07 |
|
| 6878705 |
4-oxo-4,7-dihydrofuro[2,3-b]pyridine-5-carboxamide antiviral agents |
Michele M. Cudahy, Steven P. Tanis, William R. Perrault, Paul Herrinton, Sajiv Krishnan Nair |
2005-04-12 |
$244,881,000 |
| 6861438 |
Antiviral agents |
Scott D. Larsen, Paul D. May, Karen Rene Romines, Steven P. Tanis |
2005-03-01 |
$134,880,000 |
| 6852731 |
Antiviral compounds |
Scott D. Larsen, Paul D. May, Karen Rene Romines, Steven P. Tanis, James A. Nieman +3 more |
2005-02-08 |
$111,158,000 |
| 6831081 |
4-Oxo-4,7-dihydrothieno[2,3-b]pyridine-5-carboxamides as antiviral agents |
Fred Lawrence Ciske, Michael James Genin, Joseph Walter Strohbach, Suvit Thaisrivongs |
2004-12-14 |
$31,853,000 |
| 6730682 |
Heterocycle carboxamides as antiviral agents |
Valerie A. Vaillancourt |
2004-05-04 |
|
| 6653307 |
1-aryl-4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents |
— |
2003-11-25 |
|
| 6624159 |
Heterocycle carboxamides as antiviral agents |
David Anderson, Gordon L. Bundy, Fred Lawrence Ciske, David R. Graber, Michael James Genin +8 more |
2003-09-23 |
|
| 6562822 |
Heterocyle carboxamides as antiviral agents |
— |
2003-05-13 |
|
| 6559145 |
Heterocycle carboxamides as antiviral agents |
Fred Lawrence Ciske, Michael James Genin, Byung-Hyun Lee, Valerie A. Vaillancourt |
2003-05-06 |
|
| 6248739 |
Quinolinecarboxamides as antiviral agents |
Steven Ronald Turner, Joseph Walter Strohbach, Suvit Thaisrivongs, Valerie A. Vaillancourt, John Tucker |
2001-06-19 |
$88,317,000 |
| 6248736 |
4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents |
Steven Ronald Turner, Joseph Walter Strohbach, Suvit Thaisrivongs, Valerie A. Vaillancourt, Allen W. Scott |
2001-06-19 |
$88,317,000 |
| 6239142 |
4-oxo-4,7-dihydro-thieno[2,3-b]pyridine-5carboxamides as antiviral agents |
Michele M. Cudahy, Allen W. Scott |
2001-05-29 |
$105,476,000 |
